美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Apimeds Pharmaceutical U.S, Inc.

5.28

+0.530011.16%

成交量：2.20萬

成交額：11.25萬

市值：796.81萬

市盈率：-0.14

高：5.34

開：4.78

低：4.78

收：4.75

52周最高：59.70

52周最低：3.39

股本：150.91萬

流通股本：30.47萬

量比：0.33

換手率：7.23%

股息：- -

股息率：- -

每股收益(TTM):-38.5450

每股收益(LYR):-0.1759

淨資產收益率：-144.99%

總資產收益率：-69.29%

市淨率：0.98

市盈率(LYR):-30.02

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

SEC文件揭示：Freet已將全部Apitox相關權利轉讓予Apimeds Pharmaceuticals

Apimeds Pharmaceuticals US獲Apitox韓國診所獨家權利、美國25%特許權使用費及海外25%收入分成——SEC文件披露

Apimeds製藥美國公司依據和解協議，將在七個工作日內設立全新全資子公司

Apimeds Pharmaceuticals US與Inscobee達成和解；合併進程繼續，1億美元PIPE融資即將完成，LŌKahi Therapeutics將推進Apitox項目

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/APUS"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"APUS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","market":"US","secType":"STK","nameCN":"Apimeds Pharmaceutical  U.S, Inc.","latestPrice":5.28,"timestamp":1787675944207,"preClose":4.75,"halted":0,"volume":22019,"delay":0,"changeRate":0.11157894736842111,"floatShares":304730,"shares":1509119,"eps":-38.545,"marketStatus":"交易中","change":0.53,"latestTime":"08-25 12:46:46 EDT","open":4.78,"high":5.342,"low":4.78,"amount":112473.8556935,"amplitude":0.118316,"askPrice":5.49,"askSize":20,"bidPrice":5.21,"bidSize":10,"shortable":0,"etf":0,"ttmEps":-38.545,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"listingDate":1746763200000,"exchange":"AMEX","adjPreClose":4.75,"preHourTrading":{"tag":"盘前","latestPrice":4.99,"preClose":4.75,"latestTime":"09:29 EDT","volume":917,"amount":4635.6801141,"timestamp":1787664590382,"change":0.24,"changeRate":0.050526,"amplitude":0.309474},"postHourTrading":{"tag":"盘后","latestPrice":4.75,"preClose":4.75,"latestTime":"19:55 EDT","volume":72,"amount":333.84,"timestamp":1787615716787,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.333043},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","floatShares":304730,"roa":"-69.29%","roe":"-144.99%","lyrEps":-0.175862,"volumeRatio":0.333043,"shares":1509119,"dividePrice":0,"high":5.342,"amplitude":0.118316,"preClose":4.75,"low":4.78,"week52Low":3.39,"pbRate":"0.98","week52High":59.7,"institutionHeld":0,"latestPrice":5.28,"committee":-0.333333,"eps":-38.545,"divideRate":0,"volume":22019,"delay":0,"ttmEps":-38.545,"open":4.78,"prevYearClose":16.4,"prevWeekClose":4.84,"prevMonthClose":5.15,"prevQuarterClose":9,"fiveDayClose":4,"twentyDayClose":8,"sixtyDayClose":14.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APUS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-24","symbol":"APUS","defaultRemindTime":1784899800000,"type":"split","dateTimestamp":1784865600000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APUS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APUS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APUS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APUS","date":"2025-12-01","current":-0.133091,"percent":0.642384,"low":-37.866629,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"high":-4.754876,"avg":-11.953693,"sd":7.073766,"marketCap":36470350},"quantilePoints":[{"date":"2025-02-21","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-02-28","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-03-05","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-05-09","current":-18.309826,"twenty":-34.716764,"median":-34.716764,"eighty":-33.299512,"marketCap":25450475},{"date":"2025-05-16","current":-14.148502,"twenty":-34.716764,"median":-34.008138,"eighty":-15.063993,"marketCap":19666276},{"date":"2025-05-23","current":-14.074662,"twenty":-34.716764,"median":-18.309826,"eighty":-14.306662,"marketCap":21054484},{"date":"2025-05-30","current":-13.387434,"twenty":-34.716764,"median":-15.063993,"eighty":-14.061031,"marketCap":20026450},{"date":"2025-06-06","current":-14.702962,"twenty":-34.716764,"median":-14.800251,"eighty":-13.996937,"marketCap":21994367},{"date":"2025-06-13","current":-14.314495,"twenty":-34.716764,"median":-14.564634,"eighty":-14.061031,"marketCap":21413253},{"date":"2025-06-20","current":-13.774354,"twenty":-33.866413,"median":-14.548195,"eighty":-14.0474,"marketCap":20605249},{"date":"2025-06-27","current":-13.296895,"twenty":-33.299512,"median":-14.356338,"eighty":-13.867215,"marketCap":19891011},{"date":"2025-07-03","current":-13.774354,"twenty":-27.303638,"median":-14.27266,"eighty":-13.727614,"marketCap":20605249},{"date":"2025-07-11","current":-14.006506,"twenty":-17.177946,"median":-14.161274,"eighty":-13.727614,"marketCap":20952529},{"date":"2025-07-18","current":-13.851738,"twenty":-15.354982,"median":-14.154888,"eighty":-13.727614,"marketCap":20721009},{"date":"2025-07-25","current":-16.173259,"twenty":-16.219689,"median":-14.161274,"eighty":-13.727614,"marketCap":24193804},{"date":"2025-08-01","current":-13.464818,"twenty":-16.219689,"median":-14.199966,"eighty":-13.727614,"marketCap":20142210},{"date":"2025-08-08","current":-12.14929,"twenty":-16.049445,"median":-14.148502,"eighty":-13.573156,"marketCap":18174293},{"date":"2025-08-15","current":-12.265366,"twenty":-15.710284,"median":-14.056061,"eighty":-13.418388,"marketCap":18347933},{"date":"2025-08-22","current":-7.697345,"twenty":-15.447843,"median":-14.006506,"eighty":-13.015991,"marketCap":28547481},{"date":"2025-08-29","current":-6.307075,"twenty":-15.306558,"median":-13.929122,"eighty":-12.721932,"marketCap":23391328},{"date":"2025-09-05","current":-6.307075,"twenty":-15.146611,"median":-13.929122,"eighty":-12.474303,"marketCap":23391328},{"date":"2025-09-12","current":-6.578348,"twenty":-15.038217,"median":-13.851738,"eighty":-12.234412,"marketCap":24397407},{"date":"2025-09-19","current":-6.205348,"twenty":-14.9276,"median":-13.774354,"eighty":-7.507455,"marketCap":23014048},{"date":"2025-09-26","current":-6.049367,"twenty":-14.889578,"median":-13.773581,"eighty":-6.849619,"marketCap":22435553},{"date":"2025-10-03","current":-5.832349,"twenty":-14.826776,"median":-13.69697,"eighty":-6.578348,"marketCap":21630690},{"date":"2025-10-10","current":-6.307075,"twenty":-14.675296,"median":-13.542202,"eighty":-6.472551,"marketCap":23391328},{"date":"2025-10-17","current":-6.239257,"twenty":-14.561346,"median":-13.50351,"eighty":-6.415584,"marketCap":23139808},{"date":"2025-10-24","current":-5.879822,"twenty":-14.548195,"median":-13.387434,"eighty":-6.358617,"marketCap":21806754},{"date":"2025-10-31","current":-6.917438,"twenty":-14.538909,"median":-13.039206,"eighty":-6.374893,"marketCap":25655005},{"date":"2025-11-07","current":-8.524725,"twenty":-14.481047,"median":-12.845746,"eighty":-6.381675,"marketCap":31616021},{"date":"2025-11-14","current":-9.460613,"twenty":-14.381444,"median":-12.652286,"eighty":-6.415584,"marketCap":35086992},{"date":"2025-11-21","current":-5.852155,"twenty":-14.312928,"median":-12.458826,"eighty":-6.415584,"marketCap":30182359},{"date":"2025-11-28","current":-7.071353,"twenty":-14.306662,"median":-12.304058,"eighty":-6.374893,"marketCap":36470350},{"date":"2025-12-01","current":-7.071353,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"marketCap":36470350}],"updateTime":1787672260892},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APUS\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1142452397","title":"SEC文件揭示：Freet已將全部Apitox相關權利轉讓予Apimeds Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=1142452397","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142452397?lang=zh_tw&edition=fundamental","pubTime":"2026-08-22 05:14","pubTimestamp":1787346850,"startTime":"0","endTime":"0","summary":"一项最新提交至美国证券交易委员会的文件显示，Apimeds Pharmaceuticals US已获得Freet方面转让的全部Apitox相关权益。这一动作意味着，围绕Apitox的所有权归属问题，如今已有了明确的界定与交接。根据该文件内容，Freet将其与Apitox相关的所有权利完整地转移给了Apimeds Pharmaceuticals。此举或将对Apimeds Pharmaceuticals未来的业务布局与产品管线产生深远影响。随着权利的正式移交，Apimeds Pharmaceuticals US如今握有更为集中的资源，未来其如何利用这一优势，值得持续关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111642266","title":"Apimeds Pharmaceuticals US獲Apitox韓國診所獨家權利、美國25%特許權使用費及海外25%收入分成——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1111642266","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111642266?lang=zh_tw&edition=fundamental","pubTime":"2026-08-22 05:14","pubTimestamp":1787346850,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会最新披露的文件，Apimeds Pharmaceuticals US已就其核心产品Apitox达成一项重要协议。该公司获得了该产品在韩国诊所领域的100%独家权利，同时在美国市场享有25%的特许权使用费，并可参与海外市场25%的收入分成。协议条款清晰界定了各区域市场的利益分配机制——韩国市场侧重权利掌控，美国及海外市场则通过收益共享模式实现多方共赢。文件内容显示，此次权利与收益分配方案已正式确立，为Apitox的全球市场推广奠定了明确的商业框架。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170470171","title":"Apimeds製藥美國公司依據和解協議，將在七個工作日內設立全新全資子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1170470171","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170470171?lang=zh_tw&edition=fundamental","pubTime":"2026-05-06 02:09","pubTimestamp":1778004553,"startTime":"0","endTime":"0","summary":"根据最新达成的和解协议条款，Apimeds制药美国公司已承诺在七个工作日的期限内完成全新全资子公司的组建工作。这一举措标志着公司在战略重组方面迈出关键一步，旨在优化业务架构并提升运营效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111825147","title":"Apimeds Pharmaceuticals US與Inscobee達成和解；合併進程繼續，1億美元PIPE融資即將完成，LŌKahi Therapeutics將推進Apitox項目","url":"https://stock-news.laohu8.com/highlight/detail?id=1111825147","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111825147?lang=zh_tw&edition=fundamental","pubTime":"2026-05-06 02:07","pubTimestamp":1778004434,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceutical U.S, Inc.已与Inscobee达成和解协议，公司合并计划将按原定方案继续推进。与此同时，一项高达1亿美元的PIPE融资也即将完成交割。\n作为合并后实体的一部分，LŌKahi Therapeutics将获得资金支持，重点推进其Apitox项目的研发进程。这一系列进展标志着公司在战略布局和资本运作方面取得重要突破。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/APUS\",params:#limit:6,delay:false,,,undefined,":[]}}